**Noah Wyle holds the strongest position among the five nominees for Outstanding Lead Actor in a Drama Series, driven by “The Pitt”’s dominant 25-nomination haul and his repeat frontrunner status after winning the category in 2025.** The HBO Max medical drama’s critical and awards momentum, including multiple acting nods, has consolidated trader consensus around Wyle’s performance as Dr. Robby Robinavitch. Gary Oldman (“Slow Horses”) and Mark Ruffalo (“Task”) sit close behind at roughly 60% implied probability, reflecting their established industry regard and strong seasons, while Rufus Sewell (“The Diplomat”) and Sterling K. Brown (“Paradise”) trail slightly amid a crowded field. With the ceremony weeks away, guild and critic momentum plus late-season buzz remain key swing factors in this closely watched race.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoEmmy 2026: Mejor actor principal en una serie dramática
Noah Wyle – “The Pitt” 52%
Mark Ruffalo – “Task” 49%
Rufus Sewell – “The Diplomat” 48%
Sterling K. Brown – “Paradise” 47%
Noah Wyle – “The Pitt”
50%
Mark Ruffalo – “Task”
49%
Rufus Sewell – “The Diplomat”
48%
Sterling K. Brown – “Paradise”
47%
Gary Oldman – “Slow Horses”
47%
Noah Wyle – “The Pitt” 52%
Mark Ruffalo – “Task” 49%
Rufus Sewell – “The Diplomat” 48%
Sterling K. Brown – “Paradise” 47%
Noah Wyle – “The Pitt”
50%
Mark Ruffalo – “Task”
49%
Rufus Sewell – “The Diplomat”
48%
Sterling K. Brown – “Paradise”
47%
Gary Oldman – “Slow Horses”
47%
This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Mercado abierto: Jul 9, 2026, 9:08 PM ET
Resolver
0x69c47De9D...This market will resolve according to the person who wins the 2026 Emmy award for “Outstanding lead actor in a drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...**Noah Wyle holds the strongest position among the five nominees for Outstanding Lead Actor in a Drama Series, driven by “The Pitt”’s dominant 25-nomination haul and his repeat frontrunner status after winning the category in 2025.** The HBO Max medical drama’s critical and awards momentum, including multiple acting nods, has consolidated trader consensus around Wyle’s performance as Dr. Robby Robinavitch. Gary Oldman (“Slow Horses”) and Mark Ruffalo (“Task”) sit close behind at roughly 60% implied probability, reflecting their established industry regard and strong seasons, while Rufus Sewell (“The Diplomat”) and Sterling K. Brown (“Paradise”) trail slightly amid a crowded field. With the ceremony weeks away, guild and critic momentum plus late-season buzz remain key swing factors in this closely watched race.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes